Paul-Ehrlich-Institut

Go to:

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Immunological Medicines for Horses

Immunological veterinary medicinal products, including vaccines, are authorised for horses.

Search results 26 to 32 from a total of 32

Name De­scrip­tion Mar­ket­ing Au­tho­ri­sa­tion Hold­er Li­cense Num­ber Li­cense Date An­i­mal Further Information

Equilis West Nile

West-Nil-Viruserkrankung

Intervet International BV, Niederlande

 EU/2/13/151/001-003 06.06.2013 Pferd

EPAR: Equilis West Nile

BioEquin H

Equines Herpesvirus (EHV) Typ 1

Bioveta, a.s., Tschechien

 PEI.V.11912.01.1 24.08.2017 Pferd

PharmNet.Bund

EquiShield EHV

Equines Herpesvirus (EHV) Typ 1

Dechra Regulatory B.V., Niederlande

 PEI.V.11982.01.1 23.01.2019 Pferd

PharmNet.Bund

Arti-Cell Forte

Allogene periphere mesenchymale Stammzellen aus dem Blut vom Pferd, chondrogeninduziert

Global Stem cell Technology (G.S.T.) NV, Belgien

 EU/2/18/228 29.03.2019 Pferd

EPAR: Arti-Cell Forte

HorStem

Mesenchymale Stammzellen vom Pferd, extrahiert aus Nabelschnur des Pferds

EquiCord-YMAS S.L., Spanien

 EU/2/18/226 19.06.2019 Pferd

EPAR:

Strangvac

Streptococcus-equi-Impfstoff

Intervacc AB, Schweden

 EU/2/21/274 16.08.2021 Pferd

EPAR: Strangvac

RenuTend

Equine allogene mesenchymale Stammzellen aus peripherem Blut mit tendogenem Priming

Boehringer Ingelheim Vetmedica GmbH

 EU/2/22/282 19.04.2022 Pferd

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 518 in BAnz AT 26.06.2024 B7.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Updated: 26.06.2024